Clinical trials
Phase 1/2 Nervous System Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Active, not recruiting | 4 |
| Recruiting | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 4D Molecular Therapeutics | 1 |
| Amylyx Pharmaceuticals Inc. | 1 |
| BBB-Therapeutics B.V. | 1 |
| Beacon Therapeutics | 1 |
| BeiGene USA, Inc. | 1 |
| Calico Life Sciences LLC | 1 |
| Catabasis Pharmaceuticals | 1 |
| Cerenome | 1 |
| Forge Biologics, Inc | 1 |
| National Institute of Mental Health (NIMH) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nervous System Diseases | 13 |
| Central Nervous System Diseases | 5 |
| Brain Diseases | 4 |
| Central Nervous System Neoplasms | 4 |
| Neoplasms | 4 |
| Neurodegenerative Diseases | 4 |
| Neuromuscular Diseases | 4 |
| Brain Neoplasms | 3 |
| Genetic Diseases, Inborn | 3 |
| Musculoskeletal Diseases | 3 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.